Clinical Trials Using BTK Inhibitor BGB-3111
Clinical trials are research studies that involve people. The clinical trials on this list are studying BTK Inhibitor BGB-3111. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
-
A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Patients With Relapsed / Refractory Chronic Lymphocytic Leukemia
This study is designed to compare the overall response rate of zanubrutinib versus ibrutinib in patients with relapsed / refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.
Location: 7 locations -
A Study Comparing Obinutuzumab and BGB-3111 Versus Obinutuzumab Alone in Treating R / R Follicular Lymphoma
The purpose of the study is to evaluate the efficacy, safety and tolerability and of BGB-3111plus obinutuzumab versus obinutuzumab alone in subjects with relapsed / refractory non-Hodgkin follicular lymphoma.
Location: 3 locations